Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic syndrome.
Qianrong Zheng, Zhenyang Cao, Jiayi Teng...
https://pubmed.ncbi.nlm.nih.gov/40287685/Actively Recruiting
Led by First Affiliated Hospital of Fujian Medical University · Updated on 2026-04-23
8000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are conducting a single-center observational registry study to create a detailed clinical and imaging database for adults with cardiovascular, kidney, and metabolic diseases. The study aims to support long-term follow-up and outcome management for these interconnected health conditions. It includes adult patients aged 18 to 80 years from the First Affiliated Hospital of Fujian Medical University, integrating both past and ongoing health data for comprehensive analysis. The study collects a wide range of patient information including clinical records, laboratory tests, medications, electrocardiography, echocardiography, vascular function assessments, carotid and abdominal ultrasounds, bone density scans, coronary CT angiography, and imaging post-processing data. It combines retrospective data entry and prospective follow-up, with active yearly follow-ups and passive monthly data updates over a period of up to five years to track health outcomes and disease progression. Participants will undergo thorough assessments including hospitalization records, diagnostic tests, and imaging studies. Researchers will monitor key health events such as the first cardiorenal composite endpoint, mortality, cardiovascular events, heart failure hospitalizations, and other related outcomes. The study aims to support risk stratification, real-world evidence gathering, and improved management pathways for cardio-renal-metabolic conditions through continuous monitoring and data integration throughout the study period.
CONDITIONS
Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome
D
Dajun Chai
H
Hailin Zhang
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
First Affiliated Hospital of Fujian Medical University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 5 years from enrollment
Participants who meet eligibility criteria are enrolled in the CKM registry cohort for structured data collection and prospective lifecycle follow-up using hospital records and clinical data.
Annual active follow-up visits with monthly passive data updates
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Qianrong Zheng, Zhenyang Cao, Jiayi Teng...
https://pubmed.ncbi.nlm.nih.gov/40287685/Juan Guerrero-Mauvecin, Natalia Villar-Gómez, Lucia Miño-Izquierdo...
https://pubmed.ncbi.nlm.nih.gov/40563333/Sophie E Claudel, Insa M Schmidt, Sushrut S Waikar...
https://pubmed.ncbi.nlm.nih.gov/39932805/Keith C Ferdinand
https://pubmed.ncbi.nlm.nih.gov/39705194/Ruixin Zhu, Ran Wang, Jingjing He...
https://pubmed.ncbi.nlm.nih.gov/39556396/Na Li, Yaqi Li, Liufu Cui...
https://pubmed.ncbi.nlm.nih.gov/39255681/Sneha Annie Sebastian, Inderbir Padda, Gurpreet Johal
https://pubmed.ncbi.nlm.nih.gov/38103820/Zhaomin Xie, Chaolun Yu, Qingmei Cui...
https://pubmed.ncbi.nlm.nih.gov/40042920/Qianqian Chen, Yixuan Zhu, Jingli Gao...
https://pubmed.ncbi.nlm.nih.gov/41272273/Aamir Javaid, Essa Hariri, Bige Ozkan...
https://pubmed.ncbi.nlm.nih.gov/40104608/First Affiliated Hospital of Fujian Medical University
Lead Sponsor